Cargando…
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
Drug-induced liver injury (DILI) is an adverse toxic hepatic clinical reaction associated to the administration of a drug that can occur both at early clinical stages of drug development, as well after normal clinical usage of approved drugs. Because of its unpredictability and clinical relevance, i...
Autores principales: | Quintás, Guillermo, Martínez-Sena, Teresa, Conde, Isabel, Pareja Ibars, Eugenia, Kleinjans, Jos, Castell, José V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380240/ https://www.ncbi.nlm.nih.gov/pubmed/34274980 http://dx.doi.org/10.1007/s00204-021-03114-z |
Ejemplares similares
-
New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids
por: Rodrigues, Daniela, et al.
Publicado: (2021) -
Application of high throughput in vitro metabolomics for hepatotoxicity mode of action characterization and mechanistic-anchored point of departure derivation: a case study with nitrofurantoin
por: Ramirez-Hincapie, Sabina, et al.
Publicado: (2023) -
Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
por: Manier, Sascha K., et al.
Publicado: (2020) -
Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver
por: Sprenger, Heike, et al.
Publicado: (2022) -
Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteers
por: Ball, Amy L., et al.
Publicado: (2021)